Investor Presentaiton

Broad and equitable access is key to durable adoption and outcome improvements GUARDANT™ 1 2 INVESTOR 20 DAY 23 High performance in detecting early- stage cancer Positive unit economics to scale shield™ Broad reimbursement & access Patient preference 3 4 107

View entire presentation